Jci_page_head_homepage_01 Jci_page_head_homepage_02
Andre Bafica, Charles A. Scanga, Charles Serhan, Fabiana Machado, Sandy White, Alan Sher, Julio Aliberti
Published in Volume 115, Issue 6
J Clin Invest. 2005; 115(6):1601–1606 doi:10.1172/JCI23949
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6

In vivo administration of a stable analog of LXA4 in M. tuberculosis–infected mice. WT or 5-lo–/– mice were infected by aerosol exposure with M. tuberculosis (300 CFU inoculum) and treated 3 times a week by gavage from days 2 to 20 with vehicle or ATLa2 at 100 ng/animal/treatment. Mice were sacrificed, and mycobacterial burdens were assessed in lungs (A) and spleens (B), 21 days after infection. Spleen cell cultures from the same animals were restimulated with purified protein derivative, and 72 hours later, IFN-γ (C) and TNF (D) levels were measured in supernatants by ELISA. Results are the mean ± SD from 5 animals per group. *P < 0.05 between groups.